|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.65 HKD | -1.44% |
|
-6.05% | -2.67% |
| Feb. 25 | Simcere Pharmaceutical Group Limited acquired Xianwei Biotechnology Co., Ltd. | CI |
| Feb. 25 | Simcere Pharmaceutical Forecasts Up to 94% Boost in 2025 Profit | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- 2096 Stock
- Consensus Simcere Pharmaceutical Group Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
